A (Very) Private Cook
Executive SummaryWith one of the industry broadest product line, Cook is a ubiquitous but little understood presence in medical devices. Much of that is due to its privately-held status, which it has parlayed into a low-key management style, stressing product innovation, strong physician relationships, and freedom from quarterly results. But critics charge that its low-key approach often leads Cook to do less in capitalizing on opportunities that other companies turn into big winners.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.